DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Turtle CJ, Hay KA, Hanafi LA. et al.
Durable molecular remissions in chronic lymphocytic leukemia treated with CD19‐specific chimeric antigen receptor‐modified T cells after failure of ibrutinib.
J Clin Oncol 2017;
35: 3010-3020
We do not assume any responsibility for the contents of the web pages of other providers.